Mark Batchelor

1.0k total citations
25 papers, 713 citations indexed

About

Mark Batchelor is a scholar working on Molecular Biology, Neurology and Nutrition and Dietetics. According to data from OpenAlex, Mark Batchelor has authored 25 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Neurology and 9 papers in Nutrition and Dietetics. Recurrent topics in Mark Batchelor's work include Prion Diseases and Protein Misfolding (13 papers), Neurological diseases and metabolism (9 papers) and Trace Elements in Health (9 papers). Mark Batchelor is often cited by papers focused on Prion Diseases and Protein Misfolding (13 papers), Neurological diseases and metabolism (9 papers) and Trace Elements in Health (9 papers). Mark Batchelor collaborates with scholars based in United Kingdom, United States and Belgium. Mark Batchelor's co-authors include John Collinge, Graham S. Jackson, Anthony R. Clarke, Samantha W. Jones, Laszlo L. P. Hosszu, Clare R. Trevitt, Jonathan P. Waltho, Julian M.C. Golec, Charles J. R. Hedgecock and Roger J. Gillespie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Mark Batchelor

24 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Batchelor United Kingdom 17 533 232 200 155 78 25 713
Carlo Selvaggini Italy 7 401 0.8× 155 0.7× 143 0.7× 93 0.6× 144 1.8× 9 597
Karin Sörgjerd Japan 11 523 1.0× 44 0.2× 28 0.1× 28 0.2× 406 5.2× 12 848
Stacy Hovde United States 10 194 0.4× 41 0.2× 14 0.1× 71 0.5× 64 0.8× 15 404
Giorgia De Franceschi Italy 11 417 0.8× 63 0.3× 43 0.2× 26 0.2× 196 2.5× 12 777
V.J. Winter Netherlands 2 314 0.6× 33 0.1× 12 0.1× 53 0.3× 30 0.4× 2 532
Jun-Mei Zhou China 10 415 0.8× 55 0.2× 39 0.2× 18 0.1× 90 1.2× 18 457
Dominik Thimm Germany 14 309 0.6× 20 0.1× 17 0.1× 117 0.8× 40 0.5× 18 558
Ariel A. Valiente‐Gabioud Argentina 10 112 0.2× 93 0.4× 42 0.2× 17 0.1× 215 2.8× 13 402
Kenneth Huang United States 13 454 0.9× 77 0.3× 5 0.0× 190 1.2× 51 0.7× 20 623
Antonio Arroyo Spain 8 326 0.6× 46 0.2× 13 0.1× 26 0.2× 77 1.0× 9 521

Countries citing papers authored by Mark Batchelor

Since Specialization
Citations

This map shows the geographic impact of Mark Batchelor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Batchelor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Batchelor more than expected).

Fields of papers citing papers by Mark Batchelor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Batchelor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Batchelor. The network helps show where Mark Batchelor may publish in the future.

Co-authorship network of co-authors of Mark Batchelor

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Batchelor. A scholar is included among the top collaborators of Mark Batchelor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Batchelor. Mark Batchelor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hill, Elizabeth, Mark Batchelor, Juan M. Ribes, et al.. (2024). Syntaxin-6 delays prion protein fibril formation and prolongs the presence of toxic aggregation intermediates. eLife. 13. 2 indexed citations
2.
Hosszu, Laszlo L. P., Mark Batchelor, Emmanuel Risse, et al.. (2023). Loss of Residues 119–136, Including the First β-strand of Human Prion Protein, Generates an Aggregation-competent Partially “Open” Form. Journal of Molecular Biology. 435(15). 168158–168158.
3.
Nahass, George R., Yong Xu, Mark Batchelor, et al.. (2021). Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium. Journal of Molecular Biology. 433(8). 166878–166878. 8 indexed citations
4.
Mok, Tze How, Akın Nihat, Mark Batchelor, et al.. (2021). Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases. Scientific Reports. 11(1). 5231–5231. 18 indexed citations
5.
Hosszu, Laszlo L. P., Rebecca Conners, Mark Batchelor, et al.. (2020). Structural effects of the highly protective V127 polymorphism on human prion protein. Communications Biology. 3(1). 402–402. 7 indexed citations
6.
Schmidt, Christian, G. Properzi, Mark Batchelor, et al.. (2015). A systematic investigation of production of synthetic prions from recombinant prion protein. Open Biology. 5(12). 150165–150165. 27 indexed citations
7.
Trevitt, Clare R., Laszlo L. P. Hosszu, Mark Batchelor, et al.. (2014). N-terminal Domain of Prion Protein Directs Its Oligomeric Association. Journal of Biological Chemistry. 289(37). 25497–25508. 16 indexed citations
8.
Porter, John, Simon Lumb, Richard J. Franklin, et al.. (2009). Discovery of 4-azaindoles as novel inhibitors of c-Met kinase. Bioorganic & Medicinal Chemistry Letters. 19(10). 2780–2784. 33 indexed citations
9.
Hosszu, Laszlo L. P., Clare R. Trevitt, Samantha W. Jones, et al.. (2009). Conformational Properties of β-PrP. Journal of Biological Chemistry. 284(33). 21981–21990. 29 indexed citations
10.
Antonyuk, S.V., Clare R. Trevitt, Graham S. Jackson, et al.. (2009). Crystal structure of human prion protein bound to a therapeutic antibody. Proceedings of the National Academy of Sciences. 106(8). 2554–2558. 95 indexed citations
11.
Reuman, Michael, Jeremy Davis, Mark Batchelor, et al.. (2008). Scalable Synthesis of the VEGF-R2 Kinase Inhibitor JNJ-17029259 Using Ultrasound-Mediated Addition of MeLi−CeCl3 to a Nitrile. The Journal of Organic Chemistry. 73(3). 1121–1123. 12 indexed citations
12.
Alexander, Rikki, Mark Batchelor, Tom Crabbe, et al.. (2008). 4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase. Bioorganic & Medicinal Chemistry Letters. 18(15). 4316–4320. 35 indexed citations
13.
Porter, John, Simon Lumb, Fabien Lecomte, et al.. (2008). Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase. Bioorganic & Medicinal Chemistry Letters. 19(2). 397–400. 45 indexed citations
14.
Lewis, Patrick A., M. Howard Tattum, Samantha W. Jones, et al.. (2006). Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation. Journal of General Virology. 87(8). 2443–2449. 28 indexed citations
15.
Hosszu, Laszlo L. P., M A Wells, Graham S. Jackson, et al.. (2005). Definable Equilibrium States in the Folding of Human Prion Protein. Biochemistry. 44(50). 16649–16657. 46 indexed citations
16.
Hosszu, Laszlo L. P., Graham S. Jackson, Clare R. Trevitt, et al.. (2004). The Residue 129 Polymorphism in Human Prion Protein Does Not Confer Susceptibility to Creutzfeldt-Jakob Disease by Altering the Structure or Global Stability of PrPC. Journal of Biological Chemistry. 279(27). 28515–28521. 67 indexed citations
17.
Moffat, David, Peter D. Davis, Jeremy Davis, et al.. (1999). 4-Pyridin-5-yl-2-(3,4,5-trimethoxyphenylamino)pyrimidines: Potent and selective inhibitors of ZAP 70. Bioorganic & Medicinal Chemistry Letters. 9(23). 3351–3356. 14 indexed citations
18.
Batchelor, Mark, Roger J. Gillespie, Julian M.C. Golec, & Charles J. R. Hedgecock. (1993). A novel application of the Dess-Martin reagent to the synthesis of an FK506 analogue and other tricarbonyl compounds. Tetrahedron Letters. 34(1). 167–170. 52 indexed citations
19.
Batchelor, Mark, et al.. (1989). Amperometric assay for the ketone body 3-hydroxybutyrate. Analytica Chimica Acta. 221. 289–294. 34 indexed citations
20.
Batchelor, Mark, et al.. (1988). Amperometric determination of total amylase. Journal of Electroanalytical Chemistry. 246(2). 307–311. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlo Selvaggini Breakdown of academic impact, for papers by Karin Sörgjerd Breakdown of academic impact, for papers by Stacy Hovde Breakdown of academic impact, for papers by Giorgia De Franceschi Breakdown of academic impact, for papers by V.J. Winter Breakdown of academic impact, for papers by Jun-Mei Zhou Breakdown of academic impact, for papers by Dominik Thimm Breakdown of academic impact, for papers by Ariel A. Valiente‐Gabioud Breakdown of academic impact, for papers by Kenneth Huang Breakdown of academic impact, for papers by Antonio Arroyo
Rankless by CCL
2026